Kokoh Inti Arebama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kokoh Inti Arebama Tbk trades at Rp78 (market cap 78.47B, 61.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.1× Kokoh Inti Arebama Tbk's market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 61.5K). Which is the better fit depends on your goals.
| KOIN | OBAT | |
|---|---|---|
Market Cap | 78.47B | 166.01B |
Volume | 61.5K | 324K |
Lot | 615 | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kokoh Inti Arebama Tbk (the company) was established on 6 Jul 2001 based on Notaries Deed No. 27. The Company’s articles of association has been amended several times, most recently by notarial deed No. 7 of Mr. Nanda Fauz Iwan, SH., dated Aug 30, 2007, concerning among others, the change board commission and Company’s capital structure. PT Kokoh Inti Arebama is an Indonesia-based distributor. The Company is engaged in the distribution of ceramic wall, floor and roof tiles under the brands Lacassa, KIA and Impresso. The Company also acts as a distributor for sanitary products under the brand Claytan, paint products under the brand Kansai Paint and cement products under the brand Jaya Mortar. The Company has one subsidiary namely PT Karya Makmur Kreasi Prima. Headquartered in Jakarta, Indonesia, the Company has 16 branch offices and two stock points.
Read more on KOIN →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →